MedTrace Logo

Sacral Erector Spinae Block for Pilonidal Sinus Surgery

NCT06577064 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 62

Last updated 2024-08-29

No results posted yet for this study

Summary

The incidence of pilonidal sinus disease (PD) is estimated to be around 26/100,000 individuals mostly men.PD can cause the development of abscess or a draining sinus tract and that may lead to a loss of productive power and long-term morbidity.Different surgical technique approaches were proposed for treatment with different rates of success.

Conditions

  • Post Operative Pain

Interventions

PROCEDURE

Sacral erector spinae plane block

30 ml of 0.2% ropivacaine will be injected in the plane between the ESM and sacrum on each side

Sponsors & Collaborators

  • Menoufia University

    lead OTHER

Principal Investigators

  • rabab M habeeb · Menoufia University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-11-01
Primary Completion
2024-06-01
Completion
2024-08-01

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06577064 on ClinicalTrials.gov